Browse by Section 100 Item List

Highly Specialised Drugs Program (Public Hospital)

For Pharmaceutical Benefits Scheme (PBS) Highly Specialised Drugs prescribed through public hospitals, claiming and approval of authority prescriptions is administered by Services Australia. Highly Specialised Drugs prescribed in public hospitals are Authority Required items. Application for authorisation can be made by either:

  • posting an Authority Prescription form and other application form(s), where applicable to Services Australia
  • using the form upload facility in Health Professional Online Services (HPOS)
  • using the Online PBS Authorities system (see www.servicesaustralia.gov.au/HPOS)
  • using the Services Australia free-call service for PBS Complex Drugs Programs enquiries (1800 700 270) or
  • using the appropriate Streamlined code.

Prescribers must quote the provider number of the hospital when applying. Maximum quantities and repeats for Highly Specialised Drugs are listed in the PBS Schedule. Authority approvals are required for prescriptions where the dose is above the determined maximum quantity and/or number of repeats.

Public hospital prescriptions for Highly Specialised Drugs can be dispensed by public hospital pharmacies and some of these prescriptions can be dispensed by a community pharmacy. A patient may be required to pay a contribution for each supply of a highly specialised drug at a similar rate to the PBS. Commonwealth subsidy is not available for hospital in-patients.

Reciprocal Health Care Agreement – Where a patient is entitled to be treated as an eligible person as a visitor from a country with which Australia has entered into a Reciprocal Health Care Agreement, the supply will be limited to the original prescription only. Repeat prescriptions for these patients are not permitted.

  • Legend
  • MPMedical Practitioner
Prescriber code Item code Name, manner of administration and form & strength Max qty
packs
Max qty
units
No. of
repeats
MP 11513Y LANREOTIDElanreotide 120 mg/0.5 mL injection, 0.5 mL syringe 2 2 5
MP 5779E LANREOTIDElanreotide 120 mg/0.5 mL injection, 0.5 mL syringe 2 2 5
MP 5777C LANREOTIDElanreotide 60 mg/0.5 mL injection, 0.5 mL syringe 2 2 5
MP 5778D LANREOTIDElanreotide 90 mg/0.5 mL injection, 0.5 mL syringe 2 2 5
MP 5780F LANTHANUMlanthanum 500 mg chewable tablet, 2 x 45 2 180 5
MP 5781G LANTHANUMlanthanum 750 mg chewable tablet, 6 x 15 2 180 5
MP 5782H LANTHANUMlanthanum 1 g chewable tablet, 6 x 15 2 180 5
MP 11064H LENALIDOMIDElenalidomide 10 mg capsule, 21 1 21 0
MP 12057N LENALIDOMIDElenalidomide 10 mg capsule, 21 1 21 1
MP 12061T LENALIDOMIDElenalidomide 10 mg capsule, 21 1 21 3
MP 12988N LENALIDOMIDElenalidomide 10 mg capsule, 21 1 21 2
MP 13661B LENALIDOMIDElenalidomide 10 mg capsule, 21 1 21 2
MP 2802L LENALIDOMIDElenalidomide 10 mg capsule, 21 1 21 3
MP 5784K LENALIDOMIDElenalidomide 10 mg capsule, 21 1 21 0
MP 11062F LENALIDOMIDElenalidomide 15 mg capsule, 21 1 21 0
MP 12026Y LENALIDOMIDElenalidomide 15 mg capsule, 21 1 21 3
MP 12062W LENALIDOMIDElenalidomide 15 mg capsule, 21 1 21 1
MP 12991R LENALIDOMIDElenalidomide 15 mg capsule, 21 1 21 2
MP 13641Y LENALIDOMIDElenalidomide 15 mg capsule, 21 1 21 2
MP 5785L LENALIDOMIDElenalidomide 15 mg capsule, 21 1 21 0
MP 11041D LENALIDOMIDElenalidomide 25 mg capsule, 21 1 21 0
MP 12036L LENALIDOMIDElenalidomide 25 mg capsule, 21 1 21 1
MP 12059Q LENALIDOMIDElenalidomide 25 mg capsule, 21 1 21 3
MP 12979D LENALIDOMIDElenalidomide 25 mg capsule, 21 1 21 2
MP 13630J LENALIDOMIDElenalidomide 25 mg capsule, 21 1 21 2
MP 5786M LENALIDOMIDElenalidomide 25 mg capsule, 21 1 21 0
MP 11029L LENALIDOMIDElenalidomide 5 mg capsule, 21 1 21 0
MP 12034J LENALIDOMIDElenalidomide 5 mg capsule, 21 1 21 3
MP 12039P LENALIDOMIDElenalidomide 5 mg capsule, 21 1 21 1
MP 12985K LENALIDOMIDElenalidomide 5 mg capsule, 21 1 21 2
MP 13636Q LENALIDOMIDElenalidomide 5 mg capsule, 21 1 21 2
MP 2799H LENALIDOMIDElenalidomide 5 mg capsule, 21 1 21 3
MP 5783J LENALIDOMIDElenalidomide 5 mg capsule, 21 1 21 0
MP 12070G LENALIDOMIDElenalidomide 10 mg capsule, 14 1 14 3
MP 12012F LENALIDOMIDElenalidomide 15 mg capsule, 14 1 14 3
MP 12019N LENALIDOMIDElenalidomide 25 mg capsule, 14 1 14 3
MP 12035K LENALIDOMIDElenalidomide 5 mg capsule, 14 1 14 3
MP 11967W LENALIDOMIDElenalidomide 5 mg capsule, 28 1 28 2
MP 11968X LENALIDOMIDElenalidomide 10 mg capsule, 28 1 28 2
MP 11964Q LENALIDOMIDElenalidomide 15 mg capsule, 28 1 28 2
MP 11913B LEVODOPA + CARBIDOPAlevodopa 20 mg/mL + carbidopa monohydrate 5 mg/mL intestinal gel, 7 x 100 mL 4 28 5
MP 9743T LEVODOPA + CARBIDOPAlevodopa 20 mg/mL + carbidopa monohydrate 5 mg/mL intestinal gel, 7 x 100 mL 8 56 5
MP 10936N LIPEGFILGRASTIMlipegfilgrastim 6 mg/0.6 mL injection, 0.6 mL syringe 1 1 11
MP 11466L LUMACAFTOR + IVACAFTORlumacaftor 200 mg + ivacaftor 125 mg tablet, 112 1 112 5
MP 11465K LUMACAFTOR + IVACAFTORlumacaftor 100 mg + ivacaftor 125 mg tablet, 112 1 112 5
MP 11866M LUMACAFTOR + IVACAFTORlumacaftor 100 mg + ivacaftor 125 mg granules, 56 sachets 1 56 5
MP 11851R LUMACAFTOR + IVACAFTORlumacaftor 150 mg + ivacaftor 188 mg granules, 56 sachets 1 56 5
MP 13798F LUMACAFTOR + IVACAFTORlumacaftor 75 mg + ivacaftor 94 mg granules, 56 sachets 1 56 5